Redeye: Nanologica - Reinitiating coverage ahead of sales ramp-up
Redeye reinitiates coverage of Nanologica with a change of lead analyst, anticipating an eventful period for the company, with good prospects for ongoing customer evaluations turning into orders in the coming year. This, in turn, could provide an upside opportunity in the share.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/